Mycophenolate mofetil in stable liver transplant patients with calcineurin inhibitor-induced renal impairment: single-center experience.
Garcia
C E
CE
Centro Terapeutico Especializado em Figado (CETEFI), Real e Benemerita Sociedade Portuguesa de Beneficencia de Sao Paulo, Sao Paulo, Brazil. drcegarcia@uol.com.br
Ribeiro
H B
HB
Garcia
R L
RL
Copstein
J L
JL
Padilla
J M
JM
Santos
T E
TE
Amaral
D D
DD
Silva
A O
AO
D'Albuquerque
L A
LA
D000328:Adult; D000368:Aged; D065095:Calcineurin Inhibitors; D016572:Cyclosporine / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007674:Kidney Diseases / Q000139:chemically induced*; D008107:Liver Diseases / Q000145:classification / Q000601:surgery; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011174:Portugal; D011183:Postoperative Complications / Q000139:chemically induced; D012189:Retrospective Studies; D013997:Time Factors
D065095:Calcineurin Inhibitors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D009173:Mycophenolic Acid